Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7435 p68
20 January 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Researchers lay groundwork for large-scale production of therapeutic proteins in eggs

Antonio Ovejero Diaz/Dreamstime.com

Hen eggs

Hen eggs: transgenic chickens could yield therapeutic proteins in egg whites

Hens may in the future be used for large-scale production of therapeutic proteins, new research published this week online suggests (PNAS Early Edition, www.pnas.org).

UK researchers created transgenic chickens by inserting certain gene sequences into embryos using lentiviral vectors derived from equine infectious anaemia virus. They demonstrated stable transmission of the integrated vectors through the germ line in two subsequent generations. The resulting “transgenes” were chosen to express either a humanised miniantibody (miR24 — a potential treatment for malignant myeloma) or human interferon beta-1a, directed by regulatory sequences from the chicken ovalbumin gene.

“We aimed to direct transgene expression to the oviduct of laying hens by utilising regulatory sequences of the ovalbumin gene to control expression of the two therapeutic proteins,” the authors explain.

Ovalbumin makes up some 54 per cent of protein within egg white; the researchers demonstrated that the transgenic hens laid eggs that contained functional recombinant therapeutic proteins.

Back to Top


©The Pharmaceutical Journal